CompletedPhase 3Other

MAC vs TIVA Ambulatory Breast Augmentation

Sponsored by Ain Shams University

NCT ID
NCT03764267
Target Enrollment
80 participants
Start Date
2014-01-01
Est. Completion
2018-01-01

About This Study

hypothesis: the combination of LA with remifentanil and ketofol \[monitored anesthesia care (MAC)\] for ambulatory breast augmentation may result in results in better QoR on day of surgery as compared with total i.v. anesthesia (TIVA) . The purpose of this study was to compare the QoR after MAC using remifentanil and ketofol with TIVA during ambulatory breast augmentation .

Conditions Studied

Breast Diseases

Interventions

  • Remifentanil
  • general anesthetic

Eligibility

Sex:FEMALE
Age:21 Years - 50 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* ASA I, II

Exclusion Criteria:

* ASA III

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source